The Global Assisted Reproductive Technologies Market report presents comprehensive information covering relevant data for businesses and investors for the period 2020-2027. The report studies historical data of Assisted Reproductive Technologies market and offers valuable insights into key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimate of the Assisted Reproductive Technology industry based on the recent technological advancements and research. It also offers valuable data to help investors formulate strategic business investment plans and capitalize on the emerging growth prospects in the Assisted Reproductive Technology market.
The study on the Global Assisted Reproductive Technologies Market is the latest report covering the impact analysis of the COVID-19 pandemic currently ongoing. The pandemic has directly affected the market by causing disruptions in global supply chains and indirectly by causing financial hardship. The Assisted Reproductive Technology market has witnessed dynamic shifts in trends and demands owing to the ongoing COVID-19 pandemic. The report provides a detailed overview of how the pandemic has affected key segments of the Assisted Reproductive Technology industry. The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall Assisted Reproductive Technology industry.
Excessive alcohol consumption, smoking, stress, delayed marriages, and strenuous workouts and sports lead to increased rates of infertility
Assisted Reproductive Technologies Market Size – USD 25.95 Billion in 2020, Market Growth – at a CAGR of 9.7%, Market Trends – Technological Advancements
Get a free sample of the report: ‘https://www.emergenresearch.com/request-sample/165
Some of the key players in the market report include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd.
The prevalence of infertility is higher among the male population across the world. Rising stress levels, shift to a sedentary lifestyle, and rising incidence of obesity are leading to fertility issues, which is propelling the growth of the assisted reproductive technologies market. A major cause of infertility among the world’s population is sexually transmitted diseases (STDs), primarily gonorrhea and chlamydia. These diseases can damage or scar the fallopian tubes in women and block and scar the reproductive structures (eg, the ejaculatory ducts), leading to infertility.
However, assisted reproductive procedures are expensive and most people in developing countries cannot afford them. Moreover, the social stigma regarding these procedures also hampers the market revenue growth.
Infertility is a multi-faceted problem involving social, cultural and economic implications, which can reach threatening proportions in countries with lower fertility rates. According to statistics published by the WHO, approximately 48 million couples and 186 million people live with infertility worldwide. The increasing incidence of ovulation problems with irregular or no periods is a common cause of infertility in women. Increased awareness of various fertility treatments among the younger generation and more women opting for such fertility treatments are driving the growth of the market. However, assisted reproductive technology procedures are expensive and most people in developing countries cannot afford them. Moreover, the social stigma regarding these procedures also hampers the market revenue growth.
Growth in revenue share of assisted reproductive technology market in Europe is driven by contribution from France, Germany and UK respectively. This can be attributed to increasing novelties in clinical practice and improved access to fertility treatments in countries in the region. In addition, the region is the first to remove the “experimental” label on egg cryopreservation. The choice to become pregnant after 30 years or more by European women creates a constant demand for assisted reproductive technologies.
The report further offers a comprehensive analysis of the value chain along with an analysis of downstream buyers and upstream raw materials. The study focuses on global trends, regulatory frameworks, and macro and microeconomic factors. The report also provides an in-depth analysis of the segment and sub-segments that are expected to dominate the market during the projected period. The report offers a forecast estimate of the market with respect to market segmentation analysis including product type, end-user industries, application spectrum, and other segments.
Emergen Research has segmented the global assisted reproductive technology market based on procedure, technology, end-use, and region:
Procedural Outlook (Revenue, USD Billion; 2018-2028)
- fresh donor
- Fresh non-donor
- Donor Frozen
- Non-donor frozen
- Egg/embryo bank
Technology Outlook (Revenue, USD Billion; 2018-2028)
- In Vitro Fertilization (IVF)
- In vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI)
- In vitro fertilization (IVF) without intracytoplasmic sperm injection (ICSI)
- Artificial insemination
- Frozen Embryo Transfer (FET)
To learn more about the report: https://www.emergenresearch.com/industry-report/assisted-reproductive-technology-market
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Fertility clinics
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- The rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
Chapter 1: Scope of the Methodology
- Definition and forecast parameters
- Methodology and forecast parameters
- Data sources
- Business trends
- Regional trends
- Product trends
- End-Use Trends
- Industry segmentation
- industry landscape
- Vendor Matrix
- Technology and innovation landscape
- Company Overview
- Financial datas
- Product Landscape
- Strategic insights
Key questions addressed in the report:
- What are the key factors driving the global Assisted Reproductive Technologies market?
- Who are the major manufacturers in this market space?
- Who are the distributors, traders and resellers in this market?
- What are the market opportunities and risks affecting vendor performance in the global Assisted Reproductive Technologies market?
- What are the sales and revenue estimates of the major manufacturers in this market over the forecast period?
Request report customization: https://www.emergenresearch.com/request-for-customization/165
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
RNA Transcriptomics Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in healthcare: https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.
Corporate Sales Specialist
Emerging Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Email: [email protected]
Facebook | LinkedIn | Twitter | Blogs